Nicholas Lydon Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Nicholas Lydon is of Blueprint Medicines Corp. Currently has a direct ownership of 58,026 shares of BPMC, which is worth approximately $5.25 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 2,242 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58K
0% 3M change
4.02% 12M change
Total Value Held $5.25 Million

Nicholas Lydon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
2,242 Added 3.72%
58,026 Common Stock
Jun 21 2023
BUY
Grant, award, or other acquisition
-
2,600 Added 4.45%
55,784 Common Stock
Jun 21 2022
BUY
Grant, award, or other acquisition
-
2,600 Added 4.66%
53,184 Common Stock
May 23 2022
BUY
Exercise of conversion of derivative security
$213,053 $19.53 p/Share
10,909 Added 17.74%
50,584 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
2,250 Added 5.37%
39,675 Common Stock
Oct 01 2020
SELL
Open market or private sale
$911,519 $92.87 p/Share
9,815 Reduced 20.78%
37,425 Common Stock
NL

Nicholas Lydon

Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC